Press release
Global Geriatric Medicines Market to Witness Positive Growth of 6% by 2026
The World Health Organization (WHO) predicts that the global geriatric population (65 and above) constitute the maximum share of world population. By 2050, the number of elderly people shall reach 2 billion, a 22% increase since the beginning of the 21st century. Naturally, there is an uptick in the prevalence of chronic ailments among people. This has also stimulated the growth of the geriatric healthcare industry.Click HERE to Get Synopsis of the Report- https://www.factmr.com/report/4746/geriatric-medicines-market
Based on the abovementioned trends, the global geriatric medicines market is anticipated to expand positively at a CAGR of 6.0% during the forecast period (2020-2026). Increased government support for elderly healthcare and technological advancements in medical assistance are other important drivers behind the growth of the geriatric medicines market.
Key Takeaways of Global Geriatric Medicines Market Study:
By therapeutics, analgesic drugs are projected to dominate the global geriatric medicines market, growing at a CAGR of 6.0% and capturing greater than two-fifth market share. Usage of painkillers such as Ibuprofen and Diclofenac to address chronic conditions such as arthritis are anticipated to drive the segment’s growth.
The antihypertensive segment is anticipated to catch up, registering a CAGR of 6.5%. Increased prevalence of hypertension owing to changing lifestyles is a key growth determinant for this segment.
For detailed insights on enhancing your product footprint, request for a sample here- https://www.factmr.com/connectus/sample?flag=S&rep_id=4746
By condition, the cardiovascular segment shall retain market hegemony over the forecast period. Projections indicate a market share exceeding two-fifths of the global geriatric medicines market. Increasing incidences of cardiac arrests and strokes among the geriatric population is anticipated to boost market prospects.
By distribution channel, hospitals are anticipated to account for the maximum market share, capturing more than half of the global geriatric medicines market. Expanding base of hospitals and surge in the number of hospital visits for treatment of various chronic diseases are poised to steer growth.
North America shall retain market leadership throughout the forecast period. The region is anticipated to expand at a CAGR of 5.9%, capturing nearly 2/5th of the global geriatric medicines market. Rising cases of diseases such as obesity, presence of key market players, emerging clinical studies and research projects are anticipated to boost the region’s growth.
Asia-Pacific shows lucrative growth prospects. Rising prevalence of diseases due to a large population base and investment in health infrastructure shall also drive the region’s growth. Asia-Pacific is poised to expand at a CAGR of 6.7%, capturing 1/5th of the global geriatric medicines market.
The coronavirus pandemic is set to leverage the geriatric medicines market. As the number of infections rise daily, the most vulnerable pool is the geriatric population. This is because they already suffer from chronic conditions, thus rendering them immunocompromised.
Key players are ensuring that their supply chains in the geriatric medicines segment is not compromised. Moreover, they are also investing in clinical trials to develop critical drug formulations which could help eradicate the coronavirus.
Astra Zeneca, for instance, has initiated a clinical trial to assess whether one of their drugs has the potential to alleviate the exaggerated immune response posed by the coronavirus infection. The trial would help assess how one of their existing medicines would help alleviate the cytokine storm associated with the coronavirus disease.
Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=RM&rep_id=4746
“The global geriatric medicines market is set to embark on a positive growth trajectory. Geriatric treatment has necessitated advancements to provide quality treatment to patients. Therefore, important manufacturers are continuously introducing new pipeline drugs for treatment of lifestyle and chronic diseases,” concludes a Fact.MR analyst.
Product Development for Pipeline Drugs and Collaborations to be Key Growth Catalysts
The global geriatric medicines market comprises of the following prominent market players: AstraZeneca, Merck & Co, Inc., Pfizer, Inc., Novartis AG, Bristol-Myers Squibb Company, Sanofi S.A., GlaxoSmithKline Plc., Eli Lilly and Company, Abbott Laboratories and Boehringer Ingelheim GmbH. Most of these companies concentrate on establishing a strong market presence through launch of new products, acquisitions & agreements and partnerships with local businesses.
For instance, Pfizer Inc., collaborated with Basilea Pharmaceutica Ltd. for marketing CRESEMBA, an anti-fungal medicine used to treat aspergillosis and mucormycosis in the Asia-Pacific in 2017. Presently, the company manufactures a wide range of products ranging from internal medicines, vaccines, oncology and rare diseases. Some of its medications are Zithromax, Zyvox, Zavicefta, Cresemba, Vfend and Tygacil.
Another important player, Merck & Co., announced in 2017 the launch of RENFLEXIS, a biosimilar of the Remicade medicine, to treat conditions such as Crohn’s Disease, Ulcerative Colitis and Rheumatoid Arthritis. Its existing product portfolio includes drugs such as Invanz for primary care and women’s health, Primaxin for Hospitals & Specialty Clinics and Cancidas for Oncology ailments.
Full Access of this Exclusive Report is Available at- https://www.factmr.com/checkout/4746/S
Looking for more information?
The research study on the global geriatric medicines market by Fact.MR incorporates an unbiased assessment of key factors and trends responsible for shaping the landscape of the global geriatric medicines market over 2020-2026. It includes a detailed assessment of key parameters that are anticipated to exert influence during 2020-2026.
Market statistics have been presented on the basis of therapeutic category (Analgesic, Anti-hypersensitive, Statins, Anti-diabetic, Proton Pump Inhibitor, Anti-coagulant and Anti-psychotic & Anti-depressant), condition (Cardiovascular, Arthritis, Diabetes, Neurological, Cancer, Osteoporosis, Respiratory and Others) and distribution channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies) across five major regions.
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email : sales@factmr.com
Website : https://www.factmr.com
Research Insight: https://www.factmr.com/report/4746/geriatric-medicines-market
Content Source: https://www.factmr.com/media-release/1507/global-geriatric-medicines-market
About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions.
We have offices in US and Dublin, whereas our global headquarter is in Dubai.While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise.
Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed.
Reach out to us with your goals, and we’ll be an able research partner.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Geriatric Medicines Market to Witness Positive Growth of 6% by 2026 here
News-ID: 2277271 • Views: …
More Releases from Fact.MR
Insights into the Medical Gloves Market to Exceed US$ 27 Billion by 2034
The global medical gloves market (医療用手袋市場) is projected to reach a valuation of over US$ 27,141.5 million by 2034, growing from an estimated worth of US$ 11,299 million in 2024, with a forecasted compound annual growth rate (CAGR) of 9.2% until 2034.
The increasing emphasis on hygiene and infection control, particularly in healthcare environments, is driving demand for medical gloves. This demand is further fueled by stringent regulations governing healthcare standards.…
Aerial Inspection Services Market is accelerate at a CAGR of 17.5% to top US$ 9. …
The global Aerial Inspection Services is expected to reach a value of US$ 1.9 billion and is projected to grow at a compound annual growth rate (CAGR) of 17.5% over the next decade, reaching US$ 9.5 billion by 2033.Drone inspection services dominate this market, accounting for approximately 90.0% of the total aerial inspection services sector. Moreover, this segment represents a significant portion, around 25.0%, of the broader drone services market,…
Bioink Market Expected to Reach US$ 1.03 Billion by 2034 with 18.8% CAGR
In 2024, the global bioink market (バイオインク市場) is estimated at US$ 185.6 million. Forecasts project a remarkable Compound Annual Growth Rate (CAGR) of 18.8%, catapulting the demand for bioinks to reach a substantial market value of US$ 1.03 billion by 2034.
Recent years have witnessed a consistent rise in the necessity for organ replacements and tissue regeneration. Innovations in these fields are anticipated to facilitate the transformation of damaged tissues into…
Bonded Magnet Market is forecast to reach a valuation of US$ 10.9 Billion by 203 …
The Bonded Magnet Market is currently valued at around US$ 5.1 billion, and it is expected to experience substantial growth in the coming years. Projections suggest that the market will reach a valuation of US$ 10.9 billion by 2032, growing at an impressive compound annual growth rate (CAGR) of 7.8% from 2022 to 2032.
Bonded magnets play a significant role in the global magnet market, accounting for approximately 14% of its…
More Releases for CAGR
Cat Litter Box Market | CAGR of 9.1% | Revenue & CAGR of 9.1%
Cat Litter Box Market Report provides precise data about the market size, commercialization aspects and revenue forecast of the industry. The global Cat Litter Box market offers a historical factsheet relevant to the strategic mergers, acquirements, joint venture activities, and partnerships spread in the Cat Litter Box market. The most advanced data has been presented in the study on the revenue numbers, product details, and sales of the major firms.…
Predictive Analytics Market Growing at Strong CAGR of CAGR of 25.31% 2019
Predictive analytics helps to extract information from the existing data. It helps in understanding the pattern and predict the trend or future for the organization. It uses what-if scenarios to predict possible risks involved in the future. Predictive analytics also helps in the optimization of the marketing campaigns and understanding of the customer behaviour for increasing the end-user response and to reduce the churn.
Predictive analytics is segmented into:
Risk management:…
Global Absorption Chillers Market Reflecting a CAGR of 7.6% CAGR through 2025
The demand for thermally-driven chillers in multiple industrial verticals is poised to grow in the immediate future. Considering the rising demand for electrical chillers in commercial, residential as well as industrial settings, the adoption of absorption chillers will gain traction at considerable rate. By consuming lesser energy than conventional electrical chillers, absorption chillers will also garner surplus demand for not using ozone-depleting chlorofluorocarbons (CFC) for chilling purposes. Persistence Market Research’s…
Aircraft Sensors Market Growing at a CAGR of 6.4% CAGR By 2022
The global aircraft sensors market is forecasted to receive a strong push in its growth momentum on the back of advancements in technologies, massive investments forwarded by private equity groups, and the elevation in the demand for aircraft. Adherence to the requirements and regulations of authorities such as local aircraft regulatory bodies and the Federal Aviation Administration (FAA) could pamper the growth of the market. Nonetheless, there could be more…
China Baby Diapers Market Reflecting a CAGR of 19.1% CAGR 2012-2017
The increasing birth rate in China has proven to be a boon for the country’s baby diaper’s market. To provide a comprehensive analysis of the growth trajectory exhibited by the China baby diapers market and study the impact of the dynamic regulatory policies on the market, Transparency Market Research (TMR) has published a report, titled “Baby Diapers Market - China Industry Analysis, Market Size, Share, Growth, Trends And Forecast, 2012…
Ecg Device Market Register a CAGR Growth of 4.1% CAGR by 2024
This region holds highest market share over the forecast period (2016-2024) and is expected to exhibit slow growth rate. The Asia Pacific is expected to be the fastest-growing region for ECG devices owing to its increasing incidence rate of cardiovascular diseases and high population.
ECG devices are experiencing a paradigm technological shift from resting ECG systems to portable Holter monitoring systems, owing to their advantages of patient mobility, low prices and…
